Skip to content

Supplier News

Amgen to buy Onyx for $10.4 billion

Amgen plans to acquire oncology specialist Onyx Pharmaceuticals Inc. in a deal valued at $10.4 billion overall. Under the acquisition agreement, announced Sunday evening, Amgen will purchase all of the outstanding shares of Onyx at $125 per share in cash. Net of estimated Onyx cash, the purchase

Mylan sANDA approved for Wellbutrin generic

Mylan Inc. has gained approval from the Food and Drug Administration for its supplemental Abbreviated New Drug Application (sANDA) providing bioequivalence study results for bupropion hydrochloride extended-release tablets (300 mg).

Yoplait Go-GURT Protein hits store shelves

Yoplait is rolling out its new Go-GURT Protein yogurt for children to stores in select markets this month. The General Mills yogurt brand said Wednesday that each tube of Go-GURT Protein has 5 grams of protein per 2.25-ounce serving, two times the protein of the leading kids’ yogurt.

TheraPearl recognized for fast growth

TheraPearl LLC has earned a spot on the Inc. 500 list of the fastest-growing companies. Daniel Baumwald, president of TheraPearl, said the maker of hot/cold therapy products received a congratulatory letter from Inc.

Lannett lengthens distribution pact with Jerome Stevens

Generic drug maker Lannett Co. has extended its distribution agreement with Jerome Stevens Pharmaceuticals Inc. Lannett said Monday that the new pact extends for five years the contract that was slated to expire in March 2014. Under the agreement, Lannett will be the exclusive U.S.

Goody to launch Athletic Collection headwraps

Goody is slated to roll out a new line of athletic-inspired hair accessories, dubbed the Goody Athletique Collection. The company said Thursday that the lightweight, breathable headwraps feature moisture-wicking fabric to pull sweat away and keep the wearer cool.